313.68
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $313.68, with a volume of 2.76M.
It is up +1.19% in the last 24 hours and down -0.88% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$310.00
Open:
$312.81
24h Volume:
2.76M
Relative Volume:
1.10
Market Cap:
$120.25B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
36.33
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+4.16%
1M Performance:
-0.88%
6M Performance:
-11.57%
1Y Performance:
-18.83%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
313.68 | 120.25B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
ABT
Abbott Laboratories
|
90.49 | 157.62B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
MDT
Medtronic Plc
|
80.13 | 102.57B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.46 | 66.08B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.66 | 51.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Seeks to Dismiss Class Action Lawsuit in Cyberattack - BankInfoSecurity
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement - Financial Times
Stryker cautious after BofA and Barclays trim targets, shares stay firm in S&P 500 - Ad-hoc-news.de
Stryker Says Data Breach Suit Built On Speculation - Law360
The Mako Robotic-Arm Assisted Surgery System from Stryker Corpprecise cuts, consistent knee and h - Ad-hoc-news.de
Stryker shows mixed analyst sentiment, shares hold firm in the S&P 500 - Ad-hoc-news.de
Stryker Corp. stock underperforms Monday when compared to competitors - MarketWatch
Stryker slides, BofA trims target on medtech slowdown - Ad-hoc-news.de
BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show? - Insider Monkey
Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Is S&P 500 Healthcare Watching Stryker’s Robotics Push? - Kalkine Media
Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run - Yahoo Finance
Stryker Corp. StockLong-term drivers in focus for this medical devices leader - Ad-hoc-news.de
Stryker StockSaturday background on the medtech group - Ad-hoc-news.de
Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
SYK News | STRYKER CORP (NYSE:SYK) - ChartMill
Stryker Corp (SYK) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stryker Corp Stock (SYK) Moved Up by 3.03% on Jun 18: What Signal Does It Send? - TradingKey
Jefferies Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $455 - 富途牛牛
Smaller incisions, bigger controlhow Stryker’s OptaBlate BVN spine tool pushes vertebral ablati - Ad-hoc-news.de
Why Stryker’s Mako SmartRobotics system is reshaping knee surgery - Ad-hoc-news.de
Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight - Law360
Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stryker Corp (SYK) Institutional Confidence - TradingKey
Stryker Corp (SYK) Shares Fall 3.0% -- What GF Score of 92 Tells Investors - GuruFocus
UNITED BANK's Stryker Corp(SYK) Holding History - GuruFocus
Stryker Corp. stock outperforms competitors despite losses on the day - MarketWatch
CAFC Affirms Denial of Preliminary Injunction for Boston Scientific in Spinal Ablation Patent Dispute Against Stryker - IPWatchdog.com
Stryker Fends Off Boston Scientific Bid to Block Ablation Device - Bloomberg Law News
Stryker Corp (SYK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stryker Corp. Stock (US8636671013): Valuation Metrics Back in Focus After Recent Move - AD HOC NEWS
Hybrid approach in the operating room, Stryker’s 1688 AIM 4K Platform targets sharper minimally in - AD HOC NEWS
Stryker Corp. Stock (US8636671013): Valuation focus as newsflow stays light - AD HOC NEWS
Stryker breaks into top 5 on our latest list of Michigan’s largest manufacturers - Crain's Grand Rapids Business
Public Employees Retirement Association of Colorado Has $76.87 Million Stake in Stryker Corporation $SYK - MarketBeat
Resources Management Corp CT ADV Grows Stock Position in Stryker Corporation $SYK - MarketBeat
Eventide Asset Management LLC Acquires 4,982 Shares of Stryker Corporation $SYK - MarketBeat
Barclays PLC Purchases 239,650 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp. Stock (US8636671013): valuation in focus for U.S. medtech heavyweight - AD HOC NEWS
State Street Corp Boosts Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Stock After 16.5% One-Year Slide Is The Market Overreacting - Yahoo Finance
Stryker Weighs Cyber Setback Against Robotics Strength And Global Growth - Yahoo Finance
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now - Yahoo Finance
BofA Securities Maintains Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $380 - Moomoo
Raiffeisen Bank International AG Increases Position in Stryker Corporation $SYK - MarketBeat
Compass Capital Management Inc. Has $57.03 Million Position in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Stryker leads ASC robotics shift on surgeon demand, BTIG says - Investing.com
Smithbridge Asset Management Inc. DE Boosts Stock Position in Stryker Corporation $SYK - MarketBeat
Stryker launches TPX HD power tool for complex orthopedic procedures - MSN
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):